Moreover, CRP is another biomarker for systematic inflammation in humans, and can be up-regulated by insulin via the IRS/PI3K signaling pathway in patients with NAFLD [44]. The gene discussed is CRP; the disease is metabolic dysfunction-associated steatotic liver disease.